Konstantinos Tsilkos

Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

B. Sands, J. Lindsay, G. Chan, 2019, Alimentary pharmacology & therapeutics.

DOP026 Efficacy and safety of dose escalation to tofacitinib 10 mg BID for patients with ulcerative colitis following loss of response on tofacitinib 5 mg BID maintenance therapy: results from OCTAVE open

B. Sands, J. Lindsay, G. Chan, 2018 .

Chronic aortic denervation decreases anxiety and impairs social memory in rats.

M. Chourdakis, D. Kouvelas, C. Pourzitaki, 2009, Life sciences.

Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply

B. Sands, J. Lindsay, G. Chan, 2020, Alimentary pharmacology & therapeutics.

Improvement in Physicianʼs Global Assessment Within 2 Weeks in Patients With Ulcerative Colitis Treated With Tofacitinib

J. Gisbert, D. Rubin, D. Quirk, 2018, American Journal of Gastroenterology.

Baseline Albumin Level Is Not a Significant Predictor of Tofacitinib Efficacy in Patients with Ulcerative Colitis: Results of Multivariate Exposure-Response Analysis

D. Rubin, A. Tinsley, G. Lichtenstein, 2018, American Journal of Gastroenterology.